Docoh
Loading...

PFE Pfizer

News

Pro users get this 30m faster
10 Health Care Stocks Showing Unusual Options Activity In Today's Session
16 Apr 21
Options
This unusual options alert can help traders discover the next big trading opportunities. Traders will search for circumstances when the market estimation of an option diverges heavily from its normal worth. Unusual trading activity could push option prices to exaggerated or underestimated levels.
Why Fauci Thinks Getting Johnson & Johnson COVID-19 Vaccine 'Back On Track' Soon Is Crucial
16 Apr 21
Biotech, General
White House Chief Medical Advisor Dr. Anthony Fauci believes U.S. regulators will make a quick decision to lift the pause on administering the Johnson & Johnson (NYSE: JNJ) COVID-19 vaccine and get the vaccine “back on track.”
UK Trial On Mix-Match COVID-19 Vaccines Expanded To Add Moderna, Novavax Shots
14 Apr 21
Biotech, News, Health Care, FDA, General
Moderna's COVID-19 Shot Provides Over 90% Effectiveness Six Months After Second Dose, Boosters Can Potentially Fight Against Variants
14 Apr 21
Biotech, News, Health Care, FDA, General
'Pfizer has ramped up production of our #COVID19 vaccine & can deliver 10% more doses to the US by the end of May than previously agreed (total of 220M) & supply the full 300M agreed on for the end of July two weeks early'
13 Apr 21
News, FDA
-tweet from company Chair, CEO, Albert Bourla https://twitter.com/AlbertBourla/status/1382064225229619202
FDA, CDC Officials Discuss Johnson & Johnson Vaccine: A 'Pause Recommendation', Resolution Timeline And Advisory
13 Apr 21
News, Health Care, FDA, Top Stories, General
The Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) handed down a recommendation to pause the use of Johnson & Johnson's (NYSE:
Why Novavax Stock Is Popping, Despite Vaccine Rollout Issues: Report
13 Apr 21
Biotech, News, Media
Novavax, Inc.
Why Vaccine Stocks Pfizer, BioNTech, Moderna And Novavax Are Higher
13 Apr 21
News, Health Care, Top Stories, Movers, Trading Ideas, General
Johnson & Johnson's (NYSE: JNJ) pain has proved to be gain for other vaccine companies, including BioNTech SE (NASDAQ: BNTX), Pfizer Inc.
UPDATE: New York Governor Cuomo Says 'All Appointments For Johnson & Johnson Vaccines Today At New York State Mass Vaccination Sights Will Be Honored With Pfizer Vaccine'
13 Apr 21
News, FDA
https://twitter.com/NYGovCuomo/status/1381954783641210884?s=20
New York Governor Andrew Cuomo Issues Statement On Johnson & Johnson Vaccine
13 Apr 21
News, FDA
https://twitter.com/NYGovCuomo/status/1381954783641210884
Benzinga Pro's Top 5 Stocks To Watch For Tuesday, Apr. 13, 2021: ZM, AGC, EQOS, WKHS, BTN
13 Apr 21
Pre-Market Outlook
Today's 5 Stock Ideas: Zoom Video Communications (ZM) - The stock market was impacted Tuesday morning by news the FDA put a pause on administering the Johnson & Johnson (JNJ) COVID-19
South African Variant Able To Elude Pfizer/BioNTech' Vaccine Protection, Israeli Study Shows: Report
12 Apr 21
Biotech, Government, News, Health Care, FDA, General
AstraZeneca Farxiga Drug Doesn't Work Against COVID-19
12 Apr 21
Biotech, News, General
AstraZeneca Plc (NASDAQ: AZN) said Monday its diabetes drug Farxiga failed to achieve the main endpoints in a late-stage trial, dubbed DARE-19, for effectiveness against COVID-19.
6 Pet Stocks And An ETF For National Pet Day
10 Apr 21
Specialty ETFs, Trading Ideas, ETFs
National Pet Day was created in 2006 to bring awareness to adopting and spoiling pets. The holiday takes place every year on April 11.
European Union Looks To Buy 1.8B Pfizer-BioNTech COVID-19 Vaccine Doses From 2022: Reuters
9 Apr 21
Biotech, Government, News, Health Care, Contracts, FDA, General
Ginkgo Bioworks, Which Prints DNA And Creates Genetically Modified Food, Exploring SPAC Deal: Report
9 Apr 21
M&A, News, IPOs
One of the largest SPACs seeking a target could be nearing a $20 billion deal to bring one of the largest privately-held biotechnology companies public.
J&J Seeks To Conduct Study For COVID-19 Vaccine In India: Reuters
9 Apr 21
Biotech, Government, News, Health Care, FDA, General
What's Going On With CELC Stock And PRVB Stock Today?
9 Apr 21
News, Downgrades, Price Target, Small Cap, Analyst Ratings
Celcuity Inc (NASDAQ: CELC) shares are trading higher after the company announced a worldwide licensing agreement with Pfizer Inc. (NYSE: PFE) to develop and commercialize gedatolisib.
Benzinga Pro's Top 5 Stocks To Watch For Friday, Apr. 9, 2021: GS, PFE, GLSI, NAKD, LHDX
9 Apr 21
Pre-Market Outlook
Today's 5 Stock Ideas: Goldman Sachs (GS) - Will report Q1 results before market open on Wednesday of next week. Pfizer (PFE) - The company will host an analyst and
The Daily Biotech Pulse: Negative Regulatory Tidings For Provention Bio, Celcuity Soars On In-licensing Deal, 2 IPOs
9 Apr 21
Biotech, News, Penny Stocks, Small Cap, FDA, IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 8)

Press releases

Pro users get this 30m faster
Thinking about trading options or stock in Apple, Advanced Micro Devices, Nio, Pfizer, or Wells Fargo?
16 Apr 21
Small Cap, Opinion, Press Releases
NEW YORK, April 16, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AAPL, AMD, NIO, PFE, and WFC.
Pfizer Invites Shareholders to Attend Virtual-Only 2021 Annual Meeting of Shareholders on April 22
15 Apr 21
Press Releases
Pfizer Inc. (NYSE:PFE) announced today that shareholders and the general public are invited to access its virtual-only 2021 Annual Meeting of Shareholders at 9:00 a.m. EDT on Thursday, April 22, 2021. As previously
Businesses Seek Comprehensive Solutions to Help Curtail the Spread of Diseases
15 Apr 21
Small Cap, Opinion, Press Releases
NEW YORK, April 15, 2021 /PRNewswire/ -- The pandemic is still a very real threat as the number of new cases spiked in the United States once again. CDC's most recent data shows that the seven-day average of new
Thinking about trading options or stock in Apple, American Airlines, Pfizer, Nio, or General Electric?
13 Apr 21
Opinion, Press Releases
NEW YORK, April 13, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AAPL, AAL, PFE, NIO, and GE. NEW YORK, April 13, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AAPL, AAL, PFE, NIO, and GE.
Myovant Sciences and Pfizer Announce First Participant Dosed in Phase 3 SERENE Study Evaluating Contraceptive Efficacy of Once-Daily Relugolix Combination Tablet
12 Apr 21
Health Care, Press Releases, General
SERENE is a Phase 3 single-arm, open-label study evaluating the contraceptive efficacy of investigational relugolix combination tablet in sexually active, healthy women ages 18-35 yearsContraceptive potential of
Thinking about trading options or stock in Apple, Carnival Corp, Nio, Pfizer, or Snap?
9 Apr 21
Opinion, Press Releases
NEW YORK, April 9, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AAPL, CCL, NIO, PFE, and SNAP.
Celcuity Announces Worldwide Licensing Agreement with Pfizer to Develop and Commercialize Gedatolisib, a First-in-Class PI3K/mTOR Inhibitor for Breast Cancer
8 Apr 21
Press Releases
-Preliminary data from 103 patients in the expansion portion of a Phase 1b clinical trial demonstrated the drug was well tolerated and anti-tumor activity was noted - Unique opportunity to leverage CELsignia platform
Pharma Companies Seeking to Improve Health Outcomes With Innovative Products
8 Apr 21
Small Cap, Opinion, Press Releases
NEW YORK, April 8, 2021 /PRNewswire/ -- Conditions such as HIV, asthma, hepatitis, and severe migraines affect the quality of life of those living with these conditions. These conditions require patients to take
Thinking about trading options or stock in Microsoft, Nio, Pfizer, Norwegian Cruise Line, or Draftkings?
7 Apr 21
Opinion, Press Releases
NEW YORK, April 7, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for MSFT, NIO, PFE, NCLH, and DKNG.
Pfizer Announces Extension of Review of New Drug Application of Abrocitinib for the Treatment of Moderate to Severe Atopic Dermatitis
7 Apr 21
Press Releases
Pfizer Inc. (NYSE:PFE) today announced that the U.S. Food and Drug Administration (FDA) has extended the priority review period for the New Drug Application (NDA) for abrocitinib for the treatment of adults and
Pfizer Invites Public to Register for Webcast of Analyst and Investor Call to Review Oncology Business on April 9, 2021
2 Apr 21
Press Releases
Pfizer Inc. (NYSE:PFE) invites investors and the general public to access a live video webcast of a presentation and conference call with investment analysts at 10 a.m. EDT on Friday, April 9, 2021. Pfizer Oncology
Pfizer and BioNTech Confirm High Efficacy and No Serious Safety Concerns Through Up to Six Months Following Second Dose in Updated Topline Analysis of Landmark COVID-19 Vaccine Study
1 Apr 21
Press Releases
Analysis of 927 confirmed symptomatic cases of COVID-19 demonstrates BNT162b2 is highly effective with 91.3% vaccine efficacy observed against COVID-19, measured seven days through up to six months after the second
Pfizer and BioNTech Confirm High Efficacy and No Serious Safety Concerns Through Up to Six Months Following Second Dose in Updated Topline Analysis of Landmark COVID-19 Vaccine Study
1 Apr 21
Press Releases
Analysis of 927 confirmed symptomatic cases of COVID-19 demonstrates BNT162b2 is highly effective with 91.3% vaccine efficacy observed against COVID-19, measured seven days through up to six months after the second
Thinking about trading options or stock in Chewy, Pfizer, Ford, Boeing, or Blink Charging?
31 Mar 21
Opinion, Press Releases
NEW YORK, March 31, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CHWY, PFE, F, BA, and BLNK.
Pfizer-BioNTech Announce Positive Topline Results of Pivotal COVID-19 Vaccine Study in Adolescents
31 Mar 21
Press Releases
In participants aged 12-15 years old, BNT162b2 demonstrated 100% efficacy and robust antibody responses, exceeding those reported in trial of vaccinated 16-25 year old participants in an earlier analysis, and was well
Pfizer-BioNTech Announce Positive Topline Results of Pivotal COVID-19 Vaccine Study in Adolescents
31 Mar 21
Press Releases
In participants aged 12-15 years old, BNT162b2 demonstrated 100% efficacy and robust antibody responses, exceeding those reported in trial of vaccinated 16-25 year old participants in an earlier analysis, and was well
EMA Approves New Storage Option for Pfizer-BioNTech Vaccine, Easing Distribution and Storage of Doses Across European Union
26 Mar 21
Press Releases
New stability data show vaccine can be stored at -25°C to -15°C for a total of two weeks and support decentralized distribution plans for vaccination at general practitioners' offices Label update offers greater
Astellas Receives Positive CHMP Opinion for XTANDI™ (enzalutamide) for Patients with Metastatic Hormone-Sensitive Prostate Cancer
26 Mar 21
Press Releases
TOKYO, March 26, 2021 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") announced today the Committee for Medicinal Products for Human Use (CHMP) of the
Joint FDA Advisory Committee Votes on Application for Tanezumab for the Treatment of Osteoarthritis Pain
25 Mar 21
Press Releases
Pfizer Inc. (NYSE:PFE) and Eli Lilly and Company (NYSE:LLY) today announced the outcome of the U.S. Food and Drug Administration (FDA) Joint Arthritis Advisory Committee and Drug Safety and Risk Management Advisory
Real-World Evidence Supports Effectiveness of First-line IBRANCE® (palbociclib) Combination Therapy in HR+, HER2- Metastatic Breast Cancer
25 Mar 21
Press Releases
First large-scale comparative effectiveness analysis of a CDK 4/6 inhibitor plus letrozole evaluating progression-free and overall survival versus letrozole alone Pfizer Inc. (NYSE:PFE) today announced the